TrialCirculation2026

Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial.

Chao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.